Boston Scientific Group (BSX) May Gain Support Only Around $6.14

Boston Scientific Group (NYSE: BSX) plunged the most in the S&P 500 Index by early afternoon dealings, sliding 9.8 percent to $7.48. The world’s second-largest maker of heart devices Boston Scientific Group (BSX) forecast earnings for 2010 that were lower than analyst estimates.

Boston Scientific Group (BSX) was subsequently downgraded to “hold” from “buy” at Deutsche Bank AG. High volumes were witnessed on Boston Scientific Group (BSX), indicating that the stock may witness further sell-off till its lower support level at $6.14.